Frequency News and Research

RSS

Data analysis reveals significant risk factors for sudden unexpected death in epilepsy

Sudden unexpected death in epilepsy (SUDEP) is the most common condition-related cause of death in chronic epilepsy. Case-control studies using living people with epilepsy as controls have aimed at identifying factors that distinguish the epilepsy patient at risk of SUDEP, but there are disagreements between studies and a lack of precision in the risk estimates attributed, in part, to the small number of cases in each study.

7 Dec 2010

New analysis evaluates association between hemolysis, mortality in patients with PNH

Alexion Pharmaceuticals, Inc. today announced the presentation of an analysis from the National Data Registry in South Korea that evaluated the association between hemolysis and mortality in patients with paroxysmal nocturnal hemoglobinuria.

7 Dec 2010

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

A gene that can cause congenital heart defects has been identified by a team of scientists, including a group from Princeton University. The discovery could lead to new treatments for those affected by the conditions brought on by the birth defect.

7 Dec 2010

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, and Galderma, a global leading pharmaceutical company dedicated exclusively to the field of dermatology, announce the expansion of their multi-year collaboration agreement. Based on positive data assessing the activity of NovaBay's Aganocide compounds against impetigo, Galderma has agreed to exercise its option for this indication.

6 Dec 2010

First patient dosed with rFVIIIFc in A-LONG trial

Biogen Idec and Swedish Orphan Biovitrum today announced that the first patient has been dosed with the companies' long-lasting recombinant Factor VIII Fc fusion protein (rFVIIIFc) in a global registrational clinical trial. The study, called A-LONG, is an open-label, multicenter, Phase 2/3 study designed to evaluate the safety, pharmacokinetics and efficacy of rFVIIIFc in previously-treated hemophilia A patients.

6 Dec 2010

Mothers exposure to farm animals and cats during pregnancy lowers risk of atopic dermatitis in children

Children whose mothers are exposed to farm animals and cats are better protected against atopic dermatitis and are less likely to develop this painful inflammation of the skin in their first two years of life. A group of researchers from the University of Zurich and other universities have published evidence supporting this theory in the Journal of Allergy & Clinical Immunology.

3 Dec 2010

Fourteen cases identified on E. coli infection related to raw milk consumption in Connecticut

Raw milk is consumed by an estimated 1-3 percent of the United States population. Raw milk and raw cheeses are responsible for almost 70 percent of reported dairy outbreaks. On July 16, 2008, the Connecticut Department of Public Health identified two unrelated children who had experienced hemolytic uremic syndrome after consuming raw milk from the same farm. The authors investigated the situation further and found more cases of people affected by raw milk from the same farm.

3 Dec 2010

Alcohol drinking pattern impacts coronary heart disease

A fascinating study published in the BMJ shows that although the French drink more than the Northern Irish each week, as they drink daily, rather than more on less occasions, the French suffered from considerably less coronary heart disease than the Northern Irish.

3 Dec 2010

One-third of LGBT youth attempt suicide

One-third of lesbian, gay, bisexual and transgender youth have attempted suicide in their lifetime -- a prevalence comparable to urban, minority youth -- but a majority do not experience mental illness, according to a report by researchers at the University of Illinois at Chicago.

2 Dec 2010

Oncolytics initiates enrollment in Phase II ovarian cancer study

Oncolytics Biotech Inc. announced today the start of enrollment in a randomized Phase II ovarian cancer study. The Gynecologic Oncology Group (GOG) is conducting the randomized Phase II trial of weekly paclitaxel versus weekly paclitaxel with REOLYSIN in patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer (GOG186H).

2 Dec 2010

Toshiba introduces women's imaging configuration for Aplio XG at RSNA 2010

Many healthcare providers use ultrasound as a first-line diagnostic tool in detecting and monitoring women's health conditions. To help meet the needs of healthcare providers administering women's imaging, Toshiba has introduced a women's imaging configuration for the Aplio™ XG at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 28 - Dec. 3, 2010.

1 Dec 2010

IBD patients with hospital-acquired infections experience increased risk of inpatient mortality

Death and length of stay are increased among hospitalized inflammatory bowel disease (IBD) patients who develop hospital-acquired infections, according to a study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute.

1 Dec 2010

Medical negligence claims could make patients wary of being treated in hospitals

Solicitors at Goodmans Law believe that the frequency with which medical negligence claims occur and are reported in the media could make patients wary of being treated in hospital.

1 Dec 2010

Age-related hearing loss associated with low serum levels of folic acid in the elderly

Age-related hearing loss (ARHL), one of the four most prevalent chronic conditions in the elderly, is associated with low serum levels of folic acid, according to new research published in the December 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Dec 2010

Annual mammography screening reduces risk of mastectomy

Having a yearly mammogram greatly reduces the risk of mastectomy following breast cancer in women between the ages of 40 and 50, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2010

Mindray upgrades M7 ultrasound, high performance DC-7 platforms at RSNA annual meeting

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced two significant upgrades for its premium M7 ultrasound and high performance DC-7 platforms at the Radiology Society of North America (RSNA) being held in Chicago, November 28 – December 2, 2010. The hand carried M7 unit (HCU), which was recently introduced in North America, will be available with an extensive variety of new transducers

From Mindray 30 Nov 2010

BioTrends releases annual syndicated publication of CKD-ND patient charts

BioTrends Research Group, Inc. released ChartTrends: Bone and Mineral Metabolism in Chronic Kidney Disease Non-Dialysis (CKD-ND), an annual syndicated publication based on patient and laboratory data collected from over 1,000 U.S.

30 Nov 2010

Amount of vegetables consumed in childhood correlated to arterial stiffness in adulthood

Eating a lot of fruits and vegetables as a child is associated with healthier arteries as an adult. The amount of vegetables consumed in childhood correlated to the amount of arterial stiffness in adulthood. Children who consistently eat lots of fruits and vegetables lower their risk of having stiff arteries in young adulthood, according to research reported in Circulation: Journal of the American Heart Association.

30 Nov 2010

ZONARE announces 11th software release for z.one ultrasound platform at RSNA 2010

ZONARE Medical Systems, Inc., a developer of high-end ultrasound solutions, today announced a new software release for its z.one ultrasound platform here at the 96th Annual Meeting of the Radiological Society of North America (RSNA), Nov. 28 – Dec. 3, 2010. Designed to continually improve image quality and system performance, the 11th software release in six years also includes new advanced software applications and transducers which further expands the clinical utility of the z.one system in radiology, obstetric and vascular imaging.

29 Nov 2010

AMAG updates product label of Feraheme Injection

AMAG Pharmaceuticals, Inc. today announced that the company has reached agreement with the U.S. Food and Drug Administration (FDA) regarding an update to the product label for Feraheme (ferumoxytol) Injection for intravenous (IV) use.

29 Nov 2010

Frequency News and Research

Data analysis reveals significant risk factors for sudden unexpected death in epilepsy

New analysis evaluates association between hemolysis, mortality in patients with PNH

Screening for CCDC40 gene mutations may help determine risk for congenital heart defects

NovaBay Pharmaceuticals, Galderma expand their multi-year collaboration agreement

First patient dosed with rFVIIIFc in A-LONG trial

Mothers exposure to farm animals and cats during pregnancy lowers risk of atopic dermatitis in children

Fourteen cases identified on E. coli infection related to raw milk consumption in Connecticut

Alcohol drinking pattern impacts coronary heart disease

One-third of LGBT youth attempt suicide

Oncolytics initiates enrollment in Phase II ovarian cancer study

Toshiba introduces women's imaging configuration for Aplio XG at RSNA 2010

IBD patients with hospital-acquired infections experience increased risk of inpatient mortality

Medical negligence claims could make patients wary of being treated in hospitals

Age-related hearing loss associated with low serum levels of folic acid in the elderly

Annual mammography screening reduces risk of mastectomy

Mindray upgrades M7 ultrasound, high performance DC-7 platforms at RSNA annual meeting

BioTrends releases annual syndicated publication of CKD-ND patient charts

Amount of vegetables consumed in childhood correlated to arterial stiffness in adulthood

ZONARE announces 11th software release for z.one ultrasound platform at RSNA 2010

AMAG updates product label of Feraheme Injection

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News